Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...
A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "Glucagon-like peptide-1 (GLP ...
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...